Home › Companies › Xenon Pharmaceuticals Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Xenon Pharmaceuticals Inc.’s Form 8-K, filed June 3, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 2, 2026: 12 items on Xenon Pharmaceuticals Inc.’s Form 8-K, filed June 3, 2026: 8 elected · 4 approved.
Significant dissent: 1 equity or compensation plan (32.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Xenon Pharmaceuticals Inc. in the interactive database Compare manager voting policies
These tallies are Xenon Pharmaceuticals Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dawn Svoronos | 82,475,281 | 4,517,221 | -- | -- | 3,407,133 | 95% | Elected | — |
| Elect Director: Gillian Cannon | 84,844,120 | 2,148,382 | -- | -- | 3,407,133 | 98% | Elected | — |
| Elect Director: Steven Gannon | 86,149,107 | 843,395 | -- | -- | 3,407,133 | 99.0% | Elected | — |
| Elect Director: Elizabeth Garofalo | 84,808,573 | 2,183,929 | -- | -- | 3,407,133 | 97% | Elected | — |
| Elect Director: Justin Gover | 86,290,281 | 702,221 | -- | -- | 3,407,133 | 99.2% | Elected | — |
| Elect Director: Patrick Machado | 86,603,916 | 388,586 | -- | -- | 3,407,133 | 99.6% | Elected | — |
| Elect Director: Ian Mortimer | 86,524,582 | 467,920 | -- | -- | 3,407,133 | 99.5% | Elected | — |
| Elect Director: Gary Patou | 86,114,511 | 877,991 | -- | -- | 3,407,133 | 99% | Elected | — |
| 2. Advisory Vote on Compensation of Named Executive Officers ("Say-on-Pay") | 82,156,320 | 4,769,025 | 67,157 | -- | 3,407,133 | 95% | Approved | — |
| 4. 2026 Equity Incentive Plan | 58,579,810 | 27,570,443 | 842,250 | -- | 3,407,133 | 68% | Approved | — |
| 5. Appointment of Auditor | 90,371,967 | -- | -- | 27,668 | -- | 99.9% | Approved | — |
| 6. Remuneration of Auditor | 90,370,029 | 2,369 | 27,237 | -- | 27,237 | 99.9% | Approved | — |
Source: Xenon Pharmaceuticals Inc., Form 8-K, filed with the SEC on June 3, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
308 asset managers disclosed a vote on at least one Xenon Pharmaceuticals Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Xenon Pharmaceuticals Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Prior year: 94.8% for (June 4, 2025 meeting) unchanged
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Dawn Svoronos
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Dawn Svoronos”): 82,475,281 for, 4,517,221 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,217,715 for, 697,649 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,852,681 | 831 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 472,520 | 54,859 | 0 | 0 | Mixed |
| Putnam | 24,994 | 499,762 | 0 | 0 | Against |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Prior year: 98.7% for (June 4, 2025 meeting) ▼ 1.2 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Elizabeth Garofalo
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Elizabeth Garofalo”): 84,808,573 for, 2,183,929 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,726,341 for, 189,023 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 472,520 | 54,859 | 0 | 0 | Mixed |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 98.7% for (June 4, 2025 meeting) ▲ 0.3 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gary Patou
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Gary Patou”): 86,114,511 for, 877,991 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,788,338 for, 127,026 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.7% for (June 4, 2025 meeting) ▼ 1.2 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Gillian Cannon
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Gillian Cannon”): 84,844,120 for, 2,148,382 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,726,341 for, 189,023 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 472,520 | 54,859 | 0 | 0 | Mixed |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Prior year: 98.9% for (June 4, 2025 meeting) ▲ 0.5 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Ian Mortimer
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Ian Mortimer”): 86,524,582 for, 467,920 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,888,487 for, 26,877 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 98.6% for (June 4, 2025 meeting) ▲ 0.6 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Justin Gover
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Justin Gover”): 86,290,281 for, 702,221 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,888,487 for, 26,877 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Prior year: 91.8% for (June 4, 2025 meeting) ▲ 7.7 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Patrick Machado
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Patrick Machado”): 86,603,916 for, 388,586 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,888,487 for, 26,877 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Prior year: 98.9% for (June 4, 2025 meeting) ▲ 0.2 pts
Description as filed by funds: To elect as directors of the Corporation the eight nominees named in the accompanying Proxy Statement and Management Information Circular to hold office until the next annual meeting of the Corporation or until their successors are duly elected: Steven Gannon
Xenon Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Steven Gannon”): 86,149,107 for, 843,395 against, per its Form 8-K filed June 3, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified:”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 89 asset managers below reported 34,888,487 for, 26,877 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 89 asset managers. All 89 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
68% Approved · of votes cast
Description as filed by funds: To approve the Corporation's 2026 Equity Incentive Plan;
Xenon Pharmaceuticals Inc.’s own tally for this item (“4. 2026 Equity Incentive Plan”): 58,579,810 for, 27,570,443 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's 2026 Equity Incentive Plan was approved as follows:”
Support: 68% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 92 asset managers below reported 28,156,126 for, 7,101,763 against, 3,000 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,503 | 9 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 563,958 | 976,561 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 348,403 | 708,084 | 0 | 0 | Mixed |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 972,237 | 0 | 0 | Against |
| Prudential/PGIM | 554,153 | 179,492 | 0 | 0 | Mixed |
| DRIEHAUS MUTUAL FUNDS | 0 | 556,793 | 0 | 0 | Against |
| Bridge Builder Trust | 16,483 | 510,896 | 0 | 0 | Against |
| Putnam | 24,994 | 499,762 | 0 | 0 | Against |
| American Century | 0 | 513,077 | 0 | 0 | Against |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 0 | 337,074 | 0 | 0 | Against |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 297,483 | 900 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 237,527 | 0 | 0 | 0 | For |
| Jackson National | 117,006 | 80,847 | 0 | 0 | Mixed |
| Allspring | 0 | 197,765 | 0 | 0 | Against |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 180,617 | 5,996 | 0 | 0 | For |
Showing the 25 largest of 92 asset managers. All 92 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 96.9% for (June 4, 2025 meeting) ▼ 2.4 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of the Corporation's named executive officers;
Xenon Pharmaceuticals Inc.’s own tally for this item (“2. Advisory Vote on Compensation of Named Executive Officers ("Say-on-Pay")”): 82,156,320 for, 4,769,025 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The compensation of the Company's named executive officers, on an advisory basis, was approved as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 0 | 513,077 | 0 | 0 | Against |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Fund voting reports, all 89 managers: 34,357,280 for, 538,293 against, 26,877 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,777,339 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 8,850,290 | 0 | 0 | 0 | For |
| Janus Henderson | 6,652,184 | 10,316 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 5,777,777 | 0 | 0 | 0 | For |
| Wellington | 4,376,421 | 0 | 0 | 0 | For |
| Capital Group | 3,340,321 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 3,138,264 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,466,939 | 0 | 0 | 0 | For |
| BlackRock | 1,743,610 | 9,492 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,615,696 | 0 | 0 | 0 | For |
| State Street | 1,476,541 | 21,012 | 0 | 0 | For |
| Holocene Advisors, LP | 1,377,262 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,334,411 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 1,318,564 | 0 | 0 | 0 | For |
| BNP Paribas Asset Management Holding S.A. | 0 | 1,276,767 | 0 | 0 | Against |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,209,433 | 38,473 | 0 | 0 | For |
| Caligan Partners LP | 1,122,615 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,098,419 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,057,108 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 962,767 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 896,256 | 0 | 0 | 0 | For |
| Affinity Asset Advisors, LLC | 867,421 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 0 | 860,073 | 0 | 0 | Against |
| Commodore Capital LP | 821,292 | 0 | 0 | 0 | For |
Institutional-manager reports, all 247 managers: 79,145,952 for, 4,245,991 against, 4 abstained, 1,335 not voted, 18,687 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Putnam | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| HARBOR FUNDS | 0 | 0 | 0 | 0 | -- |
| Loomis Sayles | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Allspring | 0 | 0 | 0 | 0 | -- |
| Hartford | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 87 managers: 147,413 for, 26,877 abstained, 34,740,388 1 year, 1 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | -- |
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| Avoro Capital Advisors LLC | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Holocene Advisors, LP | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| BNP Paribas Asset Management Holding S.A. | 0 | 0 | 0 | 0 | -- |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 0 | 0 | 0 | 0 | -- |
| Caligan Partners LP | 1,122,615 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| JENNISON ASSOCIATES LLC | 0 | 0 | 0 | 0 | -- |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | -- |
| Affinity Asset Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| Alyeska Investment Group, L.P. | 0 | 0 | 0 | 0 | -- |
| Commodore Capital LP | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 243 managers: 1,946,816 for, 435 against, 1,434 not voted, 81,045,037 1 year, 53,653 3 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% of fund votes cast · no official result
Description as filed by funds: To appoint PricewaterhouseCoopers LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation;
The 88 asset managers below reported 34,887,810 for, 26,877 withheld. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 88 asset managers. All 88 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: To authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditors of the Corporation; and
Xenon Pharmaceuticals Inc.’s own tally for this item (“6. Remuneration of Auditor”): 90,370,029 for, 2,369 against — passed, per its Form 8-K filed June 3, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The authority of the audit committee of the Board to set the remuneration of the auditor for the ensuing year was approved as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 88 asset managers below reported 34,887,810 for, 26,877 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 10,906,881 | 0 | 0 | 0 | For |
| Vanguard | 3,853,512 | 0 | 0 | 0 | For |
| BlackRock | 3,514,950 | 0 | 0 | 0 | For |
| Capital Group | 3,327,316 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,540,519 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 1,056,487 | 0 | 0 | 0 | For |
| JPMorgan | 1,016,179 | 0 | 0 | 0 | For |
| Federated Hermes | 972,237 | 0 | 0 | 0 | For |
| Prudential/PGIM | 733,645 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 556,793 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 527,379 | 0 | 0 | 0 | For |
| Putnam | 524,756 | 0 | 0 | 0 | For |
| American Century | 513,077 | 0 | 0 | 0 | For |
| AllianceBernstein | 440,294 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 337,074 | 0 | 0 | 0 | For |
| Loomis Sayles | 307,860 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 304,153 | 0 | 0 | 0 | For |
| Equitable | 298,383 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 280,558 | 0 | 0 | 0 | For |
| Jackson National | 197,853 | 0 | 0 | 0 | For |
| Allspring | 197,765 | 0 | 0 | 0 | For |
| Hartford | 194,421 | 0 | 0 | 0 | For |
| Charles Schwab | 189,080 | 0 | 0 | 0 | For |
| State Street | 186,613 | 0 | 0 | 0 | For |
| TIAA | 178,089 | 0 | 0 | 0 | For |
Showing the 25 largest of 88 asset managers. All 88 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 96,624,123 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.29% |
| 2 | Vanguard | 3.99% |
| 3 | BlackRock | 3.64% |
| 4 | Capital Group | 3.44% |
| 5 | T. Rowe Price | 1.59% |
| 6 | JANUS INVESTMENT FUND | 1.09% |
| 7 | JPMorgan | 1.05% |
| 8 | Federated Hermes | 1.01% |
| 9 | Prudential/PGIM | 0.76% |
| 10 | DRIEHAUS MUTUAL FUNDS | 0.58% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 11.15% |
| 2 | Polar Capital Holdings Plc | 9.16% |
| 3 | Janus Henderson | 6.90% |
| 4 | Avoro Capital Advisors LLC | 5.98% |
| 5 | Wellington | 4.53% |
| 6 | Capital Group | 3.46% |
| 7 | DRIEHAUS CAPITAL MANAGEMENT LLC | 3.25% |
| 8 | T. Rowe Price | 2.55% |
| 9 | BlackRock | 1.81% |
| 10 | DEERFIELD MANAGEMENT COMPANY, L.P. | 1.67% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 10,818,491 | 11.20% | Form 13F, quarter ended March 31, 2026 |
| FMR LLC | 8,824,363 | 9.13% | Proxy statement (DEF 14A), proxy filed April 22, 2026 |
| Avoro Capital Advisors LLC | 5,777,777 | 5.98% | Schedule 13G, filed May 15, 2026 |
| BlackRock | 5,640,118 | 5.84% | Form 13F, quarter ended March 31, 2026 |
| Wellington Management | 4,829,641 | 5.00% | Form 13F, quarter ended March 31, 2026 |
| JANUS HENDERSON GROUP PLC | 4,175,982 | 4.32% | Schedule 13G, filed May 15, 2026 |
| JPMorgan Chase | 1,923,610 | 1.99% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,720,533 | 1.78% | Form 13F, quarter ended March 31, 2026 |
| Ian C. Mortimer | 1,435,784 | 1.49% | Proxy statement (DEF 14A), proxy filed April 22, 2026 |
| T. Rowe Price | 1,329,591 | 1.38% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 96,624,123 shares outstanding, as reported by Xenon Pharmaceuticals Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Xenon Pharmaceuticals Inc.'s shareholder meeting held June 2, 2026, in the 2025-2026 proxy season, 308 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 4,521 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Corporation's named executive… — Xenon Pharmaceuticals Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Xenon Pharmaceuticals Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Xenon Pharmaceuticals Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Xenon Pharmaceuticals Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Xenon Pharmaceuticals (XENE) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/xenon-pharmaceuticals-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.